# Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema

> **NCT00344968** · PHASE3 · COMPLETED · sponsor: **Alimera Sciences** · enrollment: 956 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** fluocinolone acetonide
- **DRUG:** Fluocinolone Acetonide
- **PROCEDURE:** Standard of care laser photocoagulation

## Key facts

- **NCT ID:** NCT00344968
- **Lead sponsor:** Alimera Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-12
- **Final completion:** 2010-12
- **Target enrollment:** 956 (ACTUAL)
- **Last updated:** 2014-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00344968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00344968, "Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00344968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*